Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05422807
Other study ID # 1R34DK080250
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2011
Est. completion date July 2016

Study information

Verified date June 2022
Source Nemours Children's Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized, controlled pilot trial of Behavioral Family Systems Therapy for Teens with Type 2 Diabetes (BFST-DM2), an individual psychological intervention tailored to meet the needs of teens with type 2 diabetes. It is hypothesized that this behavioral family intervention will be feasible to implement with teens with type 2 diabetes and will have positive effects on treatment adherence, health outcomes like weight status and metabolic control, and psychological outcomes.


Description:

The incidence of type 2 diabetes mellitus (DM2) in youth is increasing dramatically with the rise in obesity in the U.S. and worldwide. DM2 in youth, as with adults, is clearly linked to modifiable risk factors such as obesity, sedentary lifestyle, and poor diet. Youth with DM2 are at increased risk for medical complications such as cardiovascular disease, retinopathy, and neuropathy, as well as psychological problems such as depression, anxiety, poor self-esteem, eating disorders, and poor coping and problem solving. Although there are studies demonstrating that family-based lifestyle and psychological interventions are successful in reducing obesity in youth and in improving metabolic control and adherence in youth with type 1 diabetes mellitus (DM1), very little has been published on potential lifestyle or psychological treatments for youth with DM2. Studies have shown that Behavioral Family Systems Therapy (BFST) has been effective in improving metabolic control, adherence, family communication, and problem solving in youth with DM1. This intervention could be effective in treating youth with DM2, as many of the skills necessary for good metabolic control, health outcomes, treatment adherence, and psychological adjustment are similar in both populations. This application proposes a randomized, controlled pilot trial of BFST-DM2, an individual psychological intervention tailored to meet the needs of teens with DM2. BFST will be adapted to make this intervention more feasible and relevant with minority and low-income populations and also to focus on weight management, exercise, and nutrition. The BFST-DM2 intervention includes 12 (90-minute) sessions over 6 months. Areas targeted for improvement will include metabolic control, weight/body mass index, treatment adherence, family lifestyle choices (activity, diet), family communication, and problem solving. One of the main aims of this pilot study is to gather exploratory information on the effectiveness of the BFST-DM2 intervention on measures of health outcomes, medical adherence, lifestyle changes, and family problem-solving and communication skills. In addition, it is an aim to estimate treatment effect size to determine the sample size needed to power a larger multi-site trial of the BFST-DM2 intervention. Other aims include determining factors associated with feasibility (recruitment, retention, participation, generalizability) as well as to modify the intervention to be culturally sensitive and to be more relevant to the individual needs of the DM2 adolescent population. The BFST-DM2 intervention will be compared with standard medical therapy on measures of health outcomes (metabolic control, body mass index, weight, waist circumference, body fat) physical activity (accelerometer), nutritional intake, treatment adherence, psychological adjustment (self-esteem, quality of life), family communication, and problem solving. The researchers will analyze predictors of treatment outcome and the treatment effects at the immediate post-treatment interval (6 months from baseline). Health outcomes and medical adherence data also will be collected 12 months from baseline to determine maintenance of treatment effects over time.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date July 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender All
Age group 11 Years to 17 Years
Eligibility Inclusion Criteria: - Diagnosed with type 2 diabetes mellitus for 6 months or more - Age-adjusted Body Mass Index at or above the 85th percentile (considered overweight) - Established diabetes care in Nemours Children's Clinic system or diabetes care meets minimum criteria for current American Diabetes Association Standards. - Adolescent lives at home in the study geographical area (Jacksonville, FL)over the course of the study duration (one year). - One caregiver in the home is willing to participate in the family intervention. Exclusion Criteria: - Adolescent has another systemic chronic disease other than well-controlled asthma. - Genetic syndrome or disorder (other than diabetes) known to affect glucose tolerance. - Daily use of glucocorticoids or other medications known to affect glucose tolerance. - Teen is enrolled in special education for students who have autism or are mentally handicapped. - Adolescent is pregnant or planning to be pregnant within 1 year. - Teen resides in temporary foster care, group home, or juvenile detention center. - The family has an open case with an agency investigating child abuse or neglect. - Adolescent has been in an inpatient psychiatric facility or substance abuse treatment in the past 6 months.

Study Design


Intervention

Behavioral:
BFST for Teens with Type 2 Diabetes
12 (90 minute sessions) over 6 months of Behavioral Family Systems Therapy (BFST), delivered by a Licensed clinical social worker. BFST consists of 4 components: problem-solving, communication skills training, cognitive restructuring, and functional and structural family therapy.

Locations

Country Name City State
United States Nemours Children's Clinic Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Nemours Children's Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Food Intake Nutrition/food intake is measured by the Nutrition Data Systems for Research interview baseline, 6 months after baseline
Other Family Communication Skills Family communication skills are measured by the Family Communication Interaction Behavior Code baseline, 6 months after baseline
Other Teen Self-esteem Teen Self-Perception/Self-esteem is measured by the Harter Self-Perception Profile baseline, 6 months after baseline
Other Teen Quality of Life Teen Quality of Life is measured by The Pediatric Quality of Life Inventory (PedsQL) baseline, 6 months after baseline
Primary Change in Body Mass Index (Weight Status) at 6 months and at 12 months change in Body Mass Index (adjusted for height, gender, and age), - height and weight in kg and meters (kg/m2) - change in BMI across time points is being studied - change in weight from baseline to 6 months and change in weight from baseline to 12 months baseline, 6 months after baseline, 12 months after baseline
Secondary metabolic control (HbA1c) Metabolic control is measured using HbA1c values baseline, 6 months, 12 months
Secondary Treatment Adherence Treatment Adherence is measured using the Diabetes Self Management Survey for Teens with Type 2 Diabetes. baseline, 6 months after baseline, 12 months after baseline
Secondary Family Problem-Solving Family Problem-Solving is measured using the Revised Diabetes Family Conflict Scale baseline, 6 month after baseline
Secondary Physical activity Physical activity is measured by an accelerometer baseline, 6 months after baseline
Secondary body fat (weight status) body fat percent change measured by hand-held body at impedance device baseline, 6 months after baseline, 12 months after baseline
Secondary Waist circumference (weight status) waist circumference measured in cm baseline, 6 months after baseline, 12 months after baseline
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2